STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
21 hedge funds and large institutions have $4.31M invested in Statera Biopharma, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $11K
Holders
21
Holding in Top 10
–
Calls
–
Puts
$11K
Top Buyers
| 1 | +$161K | |
| 2 | +$131K | |
| 3 | +$102K | |
| 4 |
BlackRock
New York
|
+$99.9K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$69.6K |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$431K | |
| 3 | -$194K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$192K |
| 5 |
Renaissance Technologies
New York
|
-$178K |